Stockreport

MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120

Mind Medicine (MindMed) Inc. - Common Shares  (MNMD) 
PDF - Data update includes 12-week topline Phase 2b results for MM120 in Generalized Anxiety Disorder (GAD) -- Results from Phase 1 pharmacokinetics bridging trial for MM120 [Read more]